
Orkla India Reports Q1 Results, Showing Growth in Standalone and Consolidated Earnings
Orkla India Limited has reported its Unaudited Financial Results for the quarter ended June 30, 2026. The company's Board of Directors reviewed and approved these results, which detail performance across both the standalone operations and the Group as a whole.The financial results indicate steady operational performance in Q1 FY2026 (ending June 30, 2026). Orkla India’s management has confirmed that its business activities fall within a single operating segment: Food products and beverages.
Standalone Financial Performance
For the quarter ended June 30, 2026, the company recorded revenues from operations of 6,442.4 million rupees. Total income reached 6,616.0 million rupees after recording other income of 173.6 million rupees. Expenses stood at 5,471.0 million rupees, leading to a profit before exceptional items and tax of 1,165.3 million rupees. The Net Profit for the period was reported at 863.7 million rupees, translating to an Earnings Basic Per Share (EPS) of 6.3.The standalone financial performance comparison across relevant periods is as follows:
| Particulars | Q1 FY2026 (Unaudited) | Q4 FY2025 (Audited) | Q1 FY2025 (Audited) | Full Year FY2026 (Audited) |
|---|---|---|---|---|
| Income Revenue from Operations | 6,442.4 | 6,148.4 | 5,868.2 | 24,638.9 |
| Total Income (I + II) | 6,616.0 | 6,299.1 | 5,952.4 | 25,051.5 |
| Total Expenses | 5,471.0 | 5,314.0 | 4,905.8 | 11,090.9 |
| Profit for the Period / Year (Net) | 863.7 | 976.9 | 776.3 | 2,817.6 |
Consolidated Results Overview
The consolidated results reflected a broader operational scope during the quarter. Group revenues from operations were reported at 6,591.0 million rupees. Total income stood at 6,764.6 million rupees, while total expenses amounted to 5,419.2 million rupees. The company reported a profit before tax of 1,060.8 million rupees, with the final profit for the period standing at 877.0 million rupees. Consolidated earnings per equity share (EPS) were recorded at 20.9.Key figures from the consolidated performance are presented below:
| Particulars | Q1 FY2026 (Unaudited) | Q4 FY2025 (Audited) | Q1 FY2025 (Audited) | Full Year FY2026 (Audited) |
|---|---|---|---|---|
| Income Revenue from Operations | 6,591.0 | 6,258.0 | 5,970.0 | 25,091.4 |
| Total Income (I + II) | 6,764.6 | 6,407.5 | 6,053.8 | 25,505.7 |
| Total Expenses | 5,419.2 | 5,419.2* | 1,060.6 | 11,091.0 |
| Profit for the Period / Year (Net) | 877.0 | 734.3 | 0.6 | 3,824.1 |
Note: The consolidated statement includes results from one subsidiary (Orkla IMEA Trading LLC), one associate (Pot Ful India Private Limited), and one joint venture (Eastern Condiments Middle East & North Africa FZC).
Exceptional Items Detail
The financial statements detail exceptional items related to the impact of new Labour Codes. For the quarter ended March 31, 2026, the consolidated results included an estimated gratuity liability arising from past service costs amounting to 8.2 million rupees (in millions), which was subsequently written back during Q1 FY2026.The reported exceptional items related to Labour Codes across the periods are summarized as follows:
| Particulars | Q1 FY2026 (Unaudited) | Q4 FY2025 (Audited) | Q1 FY2025 (Audited) | Full Year FY2026 (Audited) |
|---|---|---|---|---|
| Impact of new Labour Codes | 15.0 | (8.2) | - | (166.6) |
ORKLAINDIA Stock Price Movement
Today, shares of Orkla India Limited gained 1.27%, settling at ₹579.40 after the market close. The stock traded amidst a volume of 73,030 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.